This article was originally published on ETFTrends.com.
The cost of sequencing a human genome has dropped significantly over the past years and genome editing is enabling new breakthroughs in medicine. On the upcoming webcast, The Power of Genome Editing: What Investors Should Know, Manisha Samy, Analyst Genomic Revolution at ARK Invest, and Renato Leggi, Product Specialist for ARK Invest, will touch upon […]
Continue Reading Below
